NewzAn international study involving data from over four million pregnancies has confirmed that maternal vaccination against the respiratory syncytial virus (RSV) significantly decreases the risk of hospitalization in infants. The research indicates a 74 percent reduction in hospital admissions for babies whose mothers received the vaccine.
These findings provide robust evidence regarding the efficacy of prenatal immunization strategies in protecting newborns from severe RSV-related complications. The study serves as a clinical validation of current vaccination protocols aimed at reducing the burden of the virus on pediatric healthcare systems.
In-depth summary · AI, neutral